The Mediator affair continues to haunt France's second largest pharmaceutical, Servier. New revelations allege that the company falsified documents to get the pill marketed as a diabetic drug although they were aware of its appetite-suppressant qualities. Mediator was pulled off the shelves in 2009 by French health authorities amid concerns that it had fatal side-effects. We take a closer look at the latest developments.
